References
- Gold-Copd.orgGlobal Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease 2018 Report2017 Available from: http://www.goldcopd.orgAccessed November 13, 2017
- HanMKAgustiACalverleyPMChronic obstructive pulmonary disease phenotypes: the future of COPDAm J Respir Crit Care Med2010182559860420522794
- FujimotoKKitaguchiYKuboKHondaTClinical analysis of chronic obstructive pulmonary disease phenotypes classified using high-resolution computed tomographyRespirology200611673174017052301
- OstridgeKWilliamsNPKimVRelationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPDRespir Res20181913129458372
- CrossleyDRentonMKhanMLowEVTurnerAMCT densitometry in emphysema: a systematic review of its clinical utilityInt J Chron Obstruct Pulmon Dis20181354756329445272
- GaoLWenZWuCWenTOngCNMetabolic profiling of plasma from benign and malignant pulmonary nodules patients using mass spectrometry-based metabolomicsMetabolites20133353955124958138
- ManiscalcoMParisDMelckDJCoexistence of obesity and asthma determines a distinct respiratory metabolic phenotypeJ Allergy Clin Immunol201713951536154727746236
- MontuschiPParisDMelckDNMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosisThorax201267322222822106016
- WangCLiJXTangDMetabolic changes of different high-resolution computed tomography phenotypes of COPD after budesonide-formoterol treatmentInt J Chron Obstruct Pulmon Dis2017123511352129255358
- GoddardPRNicholsonEMLaszloGWattIComputed tomography in pulmonary emphysemaClin Radiol19823343793877083738
- JonesPWTabbererMChenWHCreating scenarios of the impact of COPD and their relationship to COPD Assessment Test (CAT™) scoresBMC Pulm Med2011114221835018
- JonesPWQuirkFHBaveystockCMLittlejohnsPA self-complete measure of health status for chronic airflow limitation. The St. George’s Respiratory QuestionnaireAm Rev Respir Dis19921456132113271595997
- GuyattGHBermanLBTownsendMPugsleySOChambersLWA measure of quality of life for clinical trials in chronic lung diseaseThorax198742107737783321537
- ZhangYTuYHFeiGHThe COPD assessment test correlates well with the computed tomography measurements in COPD patients in ChinaInt J Chron Obstruct Pulmon Dis20151050751425784797
- FujimotoKKitaguchiYKandaSUrushihataKHanaokaMKuboKComparison of efficacy of long-acting bronchodilators in emphysema dominant and emphysema nondominant chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2011621922721660299
- McclayJLAdkinsDEIsernNG(1)H nuclear magnetic resonance metabolomics analysis identifies novel urinary biomarkers for lung functionJ Proteome Res2010963083309020408573
- AdamkoDJNairPMayersITsuyukiRTRegushSRoweBHMetabolomic profiling of asthma and chronic obstructive pulmonary disease: A pilot study differentiating diseasesJ Allergy Clin Immunol20151365803571.e3580.e3
- AiroldiCCiaramelliCFumagalliM1H NMR To Explore the Metabolome of Exhaled Breath Condensate in α1-Antitrypsin Deficient Patients: A Pilot StudyJ Proteome Res201615124569457827646345
- WangLTangYLiuSMetabonomic profiling of serum and urine by (1)H NMR-based spectroscopy discriminates patients with chronic obstructive pulmonary disease and healthy individualsPLoS One201386e6567523755267
- KaoCCHsuJWBandiVHananiaNAKheradmandFJahoorFGlucose and pyruvate metabolism in severe chronic obstructive pulmonary diseaseJ Appl Physiol20121121424722016370
- LauEMazerJCarinoGInhaled β-agonist therapy and respiratory muscle fatigue as under-recognised causes of lactic acidosisBMJ Case Rep20132013bcr2013201015
- AgarwalARYinFCadenasEShort-term cigarette smoke exposure leads to metabolic alterations in lung alveolar cellsAm J Respir Cell Mol Biol201451228429324625219
- AgarwalARYinFCadenasEMetabolic shift in lung alveolar cell mitochondria following acrolein exposureAm J Physiol Lung Cell Mol Physiol201330510L764L77324056970
- PouwEMScholsAMDeutzNEWoutersEFPlasma and muscle amino acid levels in relation to resting energy expenditure and inflammation in stable chronic obstructive pulmonary diseaseAm J Respir Crit Care Med199815837978019731007
- RenXMaSWangJComparative effects of dexamethasone and bergenin on chronic bronchitis and their anti-inflammatory mechanisms based on NMR metabolomicsMol Biosyst20161261938194727098339
- KilkKAugAOttasASoometsUAltrajaSAltrajaAPhenotyping of Chronic Obstructive Pulmonary Disease Based on the Integration of Metabolomes and Clinical CharacteristicsInt J Mol Sci2018193666
- TakagiHTakaokaMKawaguchiAKuboYEffect of L-proline on sake brewing and ethanol stress in Saccharomyces cerevisiaeAppl Environ Microbiol200571128656866216332860
- Effenberger-NeidnichtKJägersJVerhaeghRde GrootHGlycine selectively reduces intestinal injury during endotoxemiaJ Surg Res2014192259259825012270
- Kumor-KisielewskaAKierszniewska-StępieńDPietrasTAssessment of leptin and resistin levels in patients with chronic obstructive pulmonary diseasePol Arch Med Wewn2013123521522023611920
- YonedaTYoshikawaMFuATsukaguchiKOkamotoYTakenakaHPlasma levels of amino acids and hypermetabolism in patients with chronic obstructive pulmonary diseaseNutrition2001172959911240335
- LeverMSlowSThe clinical significance of betaine, an osmolyte with a key role in methyl group metabolismClin Biochem201043973274420346934
- JungJKimSHLeeHSSerum metabolomics reveals pathways and biomarkers associated with asthma pathogenesisClin Exp Allergy201343442543323517038
- HanYYBlatterJBrehmJMFornoELitonjuaAACeledónJCDiet and asthma: vitamins and methyl donorsLancet Respir Med201311081382224461761
- SharmaSLitonjuaAAsthma, allergy, and responses to methyl donor supplements and nutrientsJ Allergy Clin Immunol201413351246125424360248
- FimognariFLLoffredoLdi SimoneSHyperhomocysteinaemia and poor vitamin B status in chronic obstructive pulmonary diseaseNutr Metab Cardiovasc Dis200919965465919282159
- ChambaneauAFilaireMJubertLBremondMFilaireENutritional Intake, Physical Activity and Quality of Life in COPD PatientsInt J Sports Med201637973073727286177
- ZhangJQZhangJQFangLZLiuLFuWPDaiLMEffect of oral N-acetylcysteine on COPD patients with microsatellite polymorphism in the heme oxygenase-1 gene promoterDrug Des Devel Ther2015963796387
- ZhangJQZhangJQLiuHEffect of N-acetylcysteine in COPD patients with different microsomal epoxide hydrolase genotypesInt J Chron Obstruct Pulmon Dis20151091792325999707
- CazzolaMCalzettaLPageCInfluence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysisEur Respir Rev20152413745146126324807
- PoolePChongJCatesCJMucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary diseaseCochrane Database Syst Rev20157CD001287
- BrosnanJTInterorgan amino acid transport and its regulationJ Nutr20031336 Suppl 120682072
- van ThoNOgawaETrang leTHA mixed phenotype of airway wall thickening and emphysema is associated with dyspnea and hospitalization for chronic obstructive pulmonary diseaseAnn Am Thorac Soc201512798899625844673
- KuhnKSMuscaritoliMWischmeyerPStehlePGlutamine as indispensable nutrient in oncology: experimental and clinical evidenceEur J Nutr201049419721019936817
- UbhiBKRileyJHShawPAMetabolic profiling detects biomarkers of protein degradation in COPD patientsEur Respir J201240234535522183483
- LaurentMRicardJ-LBahainJ-JVoinchetPRousseauLDatation du site Paléolithique moyen de la Butte d’Arvigny (Moissy-Cramayel, Seine-et-Marne)Comptes Rendus de l’Académie des Sciences – Series IIA – Earth and Planetary Science20003308581583
- DasUNPyruvate is an endogenous anti-inflammatory and anti-oxidant moleculeMed Sci Monit2006125Ra79Ra8416641887